Here's Why You Should Hold Surmodics (SRDX) Stock for Now [Yahoo! Finance]
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
The optimism led by a solid first-quarter fiscal 2024 performance and its consistent efforts to boost research and development (R&D) are expected to contribute further. Yet, concerns regarding regulatory headwinds and reliance on third parties persist. Over the past year, this Zacks Rank #3 (Hold) stock has gained 57.2% compared with the 5.6% rise of the industry and the S&P 500's 29.3% growth. The renowned medical device and in-vitro diagnostics technology provider has a market capitalization of $395.6 million. Surmodics projects 87.5% growth for fiscal 2025 and is expecting to maintain its strong performance. SRDX's earnings surpassed the Zacks Consensus Estimate in all the trailing four quarters, the average earnings surprise being 140.7%. Image Source: Zacks Investment Research Let's delve deeper. Consistent Efforts to Boost R&D: Surmodics' solid efforts to improve its R&D stature have been a key growth driver, which raises our optimism. The company's whole product solut
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics, Inc. (NASDAQ: SRDX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1Business Wire
- Surmodics, Inc. (NASDAQ: SRDX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years [Yahoo! Finance]Yahoo! Finance
- Surmodics, Inc. (NASDAQ: SRDX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $47.00 price target on the stock.MarketBeat
SRDX
Earnings
- 2/1/24 - Beat
SRDX
Sec Filings
- 2/13/24 - Form SC
- 2/12/24 - Form 8-K
- 2/12/24 - Form 4
- SRDX's page on the SEC website